DE60110096D1 - Varianten des allergenen proteins phl p 1 aus phleum pratense - Google Patents

Varianten des allergenen proteins phl p 1 aus phleum pratense

Info

Publication number
DE60110096D1
DE60110096D1 DE60110096T DE60110096T DE60110096D1 DE 60110096 D1 DE60110096 D1 DE 60110096D1 DE 60110096 T DE60110096 T DE 60110096T DE 60110096 T DE60110096 T DE 60110096T DE 60110096 D1 DE60110096 D1 DE 60110096D1
Authority
DE
Germany
Prior art keywords
variants
phleum pratense
allergenic protein
phl
protein phl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60110096T
Other languages
English (en)
Other versions
DE60110096T3 (de
DE60110096T2 (de
Inventor
Monica Sturaro
Angelo Viotti
Paolo Falagiani
Giovanni Mistrello
Daniela Roncarolo
Stefania Zanotta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consiglio Nazionale delle Richerche CNR
Original Assignee
Consiglio Nazionale delle Richerche CNR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11445783&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60110096(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Consiglio Nazionale delle Richerche CNR filed Critical Consiglio Nazionale delle Richerche CNR
Publication of DE60110096D1 publication Critical patent/DE60110096D1/de
Application granted granted Critical
Publication of DE60110096T2 publication Critical patent/DE60110096T2/de
Publication of DE60110096T3 publication Critical patent/DE60110096T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60110096T 2000-09-12 2001-09-11 Varianten des allergenen proteins phl p 1 aus phleum pratense Expired - Lifetime DE60110096T3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT2000MI001987A IT1318692B1 (it) 2000-09-12 2000-09-12 Varianti di proteine allergeniche di phleum pratense.
ITMI20001987 2000-09-12
PCT/EP2001/010485 WO2002022679A2 (en) 2000-09-12 2001-09-11 Variants of phleum pratense allergenic proteins
EP01976216A EP1317484B2 (de) 2000-09-12 2001-09-11 Varianten des allergenen proteins phl p 1 aus phleum pratense

Publications (3)

Publication Number Publication Date
DE60110096D1 true DE60110096D1 (de) 2005-05-19
DE60110096T2 DE60110096T2 (de) 2006-03-02
DE60110096T3 DE60110096T3 (de) 2011-07-21

Family

ID=11445783

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60110096T Expired - Lifetime DE60110096T3 (de) 2000-09-12 2001-09-11 Varianten des allergenen proteins phl p 1 aus phleum pratense

Country Status (8)

Country Link
US (1) US7029686B2 (de)
EP (1) EP1317484B2 (de)
AT (1) ATE293128T1 (de)
AU (1) AU2001295558A1 (de)
DE (1) DE60110096T3 (de)
ES (1) ES2238487T5 (de)
IT (1) IT1318692B1 (de)
WO (1) WO2002022679A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2323687C (en) * 1998-03-16 2008-11-25 Alk-Abello A/S Mutant recombinant allergens
US20030175312A1 (en) * 2000-11-16 2003-09-18 Alk-Abello A/S Novel mutant allergens
CA2495825C (en) 2002-08-19 2015-03-17 Merck Patent Gesellschaft Mit Beschraenkter Haftung Variants of the major allergen phl p 1 from timothy grass
ES2434720T3 (es) 2003-06-04 2013-12-17 Merck Patent Gmbh Derivados de LOL P 5 con alergenicidad reducida y reactividad frente a células T mantenida
ITMI20112301A1 (it) * 2011-12-19 2013-06-20 Lofarma Spa Varianti ipoallergeniche dell'allergene maggiore phl p 5 di phleum pratense
GB201200259D0 (en) * 2012-01-09 2012-02-22 Ohlin Per M Novel therapies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19713001A1 (de) * 1997-03-27 1998-10-01 Merck Patent Gmbh Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung
AU743647B2 (en) * 1998-01-31 2002-01-31 Mt. Sinai School Of Medicine Of New York University Methods and reagents for decreasing allergic reactions
CA2323687C (en) * 1998-03-16 2008-11-25 Alk-Abello A/S Mutant recombinant allergens

Also Published As

Publication number Publication date
WO2002022679A2 (en) 2002-03-21
ATE293128T1 (de) 2005-04-15
US20020064530A1 (en) 2002-05-30
ES2238487T5 (es) 2011-04-08
EP1317484B1 (de) 2005-04-13
US7029686B2 (en) 2006-04-18
DE60110096T3 (de) 2011-07-21
DE60110096T2 (de) 2006-03-02
ITMI20001987A1 (it) 2002-03-12
EP1317484A2 (de) 2003-06-11
WO2002022679A3 (en) 2002-05-30
IT1318692B1 (it) 2003-08-27
ES2238487T3 (es) 2005-09-01
ITMI20001987A0 (it) 2000-09-12
EP1317484B2 (de) 2011-01-05
AU2001295558A1 (en) 2002-03-26

Similar Documents

Publication Publication Date Title
CY1108211T1 (el) Προφυλακτικη και θεραπευτικη αγωγη των μολυσματικων, αυτοανοσων και αλλεργικων νοσων με ενωσεις βασης μονοσακχαριτη
ATE374204T1 (de) Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen
NO20005887L (no) Forbindelser med IgE-påvirkende egenskaper
DE60227658D1 (de) Verfahren zur behandlung neurodegenerativer, psychiatrischer und anderer störungen mit deacetylaseinhibitoren
ATE389649T1 (de) Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen
DE60233265D1 (de) 5-sulfanyl-4h-1,2,4-triazolderivate und deren verwendung zur behandlung von somatostatine vermittelten krankheiten
DE60226702D1 (de) Lang wirkendes glucagon-ähnliches peptid-2 für die behandlung von gastrointestinalen krankheiten und störungen
NO20032695L (no) Karboksamidderivater og deres anvendelse ved behandling av tromboemboliskesykdommer
NO20034360L (no) Produkter og fremgangsmåter for å forbedre tannhelsen av dyr
ATE247989T1 (de) Behandlung von in der luft suspendierten allergenen
CY1110727T1 (el) Παρασκευασματα θετικων κατα gram βακτηριων για τη θεραπεια ασθενειων που περιλαμβανουν μια ανοσολογικη δυσρυθμιση
ATE411801T1 (de) Verwendung von oxindol-derivaten bei der behandlung von demenzbedingten krankheiten, alzheimer-krankheit und erkrankungen im zusammenhang mit glykogen-synthase-kinase-3
DE60330693D1 (de) WuRMEBEHANDLUNGSVERFAHREN UND WuRMEBEHANDLUNGSVORRICHTUNG
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
WO2004076481A3 (en) Hypoallergenic der p 1 and der p 3 proteins from dermatographoides pteronyssinus
ATE293128T1 (de) Varianten des allergenen proteins phl p 1 aus phleum pratense
ID27576A (id) Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun
AU2003297001A8 (en) Compositions comprising silicone-in-water emulsions and fragrances and hair care preparations comprising such compositions
NO20032340D0 (no) Substituerte derivater av aminofuran-2-yl-eddiksyre og aminotien-2-yl-eddiksyre og deres anvendelse for behandling av migrene og smerte
EE200400074A (et) Koostised ning nende kasutamine proliferatiivsetehaiguste raviks
EP1416795A4 (de) Zusammensetzungen und verfahren zur behandlung von krankheiten der mitochondrien
CY1106740T1 (el) Παραλλαγες του μειζονος αλλεργιογονου par j 2 του φυτου περδικακι
ATE290081T1 (de) Parietaria judaica ns-ltp-antigenvarianten, entsprechende pharmazeutische zusammensetzungen und ihre verwendung
DE60120961D1 (de) Disulfid-derivate verwendbar zur behandlung von allergischen erkrankungen
ATE223725T1 (de) Pflanzliches antivirales mittel

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings